Charles River Laboratories Interna

Ultime notizie

Titoli nella lingua originale della fonte.

• Charles River Laboratories International Inc. stock underperforms Thursday when compared to competitors (si apre in una nuova scheda)

  MarketWatch · 1 ott 2026

• Charles River Associates Adds Harvard Professor Feng Zhu to Antitrust Practice (si apre in una nuova scheda)

  citybiz · 1 ott 2026

• Charles River Associates (CRAI) Expands Expertise with Harvard's Professor Feng Zhu Joining Antitrust Practice (si apre in una nuova scheda)

  GuruFocus · 1 ott 2026

• Charles River Associates (CRA) Adds Harvard Business School Professor as Academic Affiliate to Antitrust & Competition Economics Practice (si apre in una nuova scheda)

  Yahoo Finance · 1 ott 2026

• Charles River Labs Q3 Results: Adj EPS Expected At $2.90 - $3.00 (si apre in una nuova scheda)

  scanx.trade · 30 set 2026

• UBS Upgrades Charles River Laboratories International to Buy From Neutral, Adjusts Price Target to $357 From $175 (si apre in una nuova scheda)

  Moomoo · 30 set 2026

• UBS resumes Charles River Labs stock coverage with buy rating By Investing.com (si apre in una nuova scheda)

  Investing.com Nigeria · 30 set 2026

• UBS resumes Charles River Labs stock coverage with buy rating (si apre in una nuova scheda)

  Investing.com · 30 set 2026

• UBS Initiates Buy on Charles River Laboratories (CRL) Amid Positive CRO Sector Outlook (si apre in una nuova scheda)

  GuruFocus · 30 set 2026

• UBS Resumes Charles River Labs (CRL) at Buy (si apre in una nuova scheda)

  StreetInsider · 30 set 2026

• Return on invested capital % of Charles River Laboratories International, Inc. – HAN:RV6 (si apre in una nuova scheda)

  TradingView · 29 set 2026

• Charles River Laboratories International, Inc. Income Statement – HAN:RV6 (si apre in una nuova scheda)

  TradingView · 29 set 2026

• Charles River Associates Names Patrick Hillan Vice President in Life Sciences Practice (si apre in una nuova scheda)

  citybiz · 29 set 2026

• Charles River Associates adds VP to life sciences unit By Investing.com (si apre in una nuova scheda)

  Investing.com Canada · 29 set 2026

• PMGC Unit Working With Charles River Laboratories for Muscle Health Probiotic Testing (si apre in una nuova scheda)

  Yahoo Finance · 29 set 2026

• Charles River Associates (CRA) Names Patrick Hillan Vice President, Expanding Life Sciences Commercial Strategy Expertise (si apre in una nuova scheda)

  Yahoo Finance · 29 set 2026

• NorthStrive Biosciences Partners with Charles River (si apre in una nuova scheda)

  GlobeNewswire · 29 set 2026

• Why Boston’s long-awaited electric ferry still hasn’t launched on the Charles River (si apre in una nuova scheda)

  MassLive.com · 29 set 2026

• Charles River Laboratories stock at USD 294.59 on September 28, 2026 (si apre in una nuova scheda)

  AD HOC NEWS · 28 set 2026

• No more jumping across the Charles River (si apre in una nuova scheda)

  universalhub.com · 28 set 2026

• Jefferies Maintains Charles River(CRL.US) With Buy Rating, Raises Target Price to $340 (si apre in una nuova scheda)

  Moomoo · 28 set 2026

• Jefferies raises Charles River Labs stock price target on cost efficiency outlook (si apre in una nuova scheda)

  Investing.com · 28 set 2026

• Should Long Term Growth Targets Require Action From Charles River Labs Stock Investors? (si apre in una nuova scheda)

  Simply Wall Street · 27 set 2026

• Is Charles River Laboratories Stock Outperforming the S&P 500? (si apre in una nuova scheda)

  Barchart.com · 27 set 2026

• Rose BioSolutions Debuts as Latest CGT CDMO Following GI Partners’ Acquisition of Charles River Businesses (si apre in una nuova scheda)

  BioInformant · 27 set 2026

• CHARLES RIVER LABORATORIES : DEUTSCHE BANK RAISES TARGET PRICE TO $320 FROM $300 (si apre in una nuova scheda)

  webull.com · 26 set 2026

• Charles River Targets 5%-7% Growth, $300M Savings in 2030 Plan (si apre in una nuova scheda)

  Yahoo Finance · 26 set 2026

• TD Cowen maintains Buy rating on Charles River, $325 price target (si apre in una nuova scheda)

  TradingView · 25 set 2026

• RBC Capital maintains Outperform rating on Charles River, $322 price target (si apre in una nuova scheda)

  TradingView · 25 set 2026

• Charles River Labs Is Maintained at Overweight by Barclays (si apre in una nuova scheda)

  Moomoo · 25 set 2026